Phase I trial of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration resistant prostate cancer (mCRPC)

被引：16

作者：

Beer, T. M.

Slovin, S. F.

Higano, C. S.

Tejwani, S.

Dorff, T. B.

Stankevich, E.

Lowy, I.

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Univ Washington, Sch Med, Seattle, WA USA

[4] Henry Ford Hlth Syst, Detroit, MI USA

[5] Angeles Clin & Res Inst, Santa Monica, CA USA

[6] Medarex Inc, Bloomsbury, NJ USA

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.5004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5004

引用

页数：1